Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1842)	2/25/1999 7:06:00 PM
From: j_fir2	Read Replies (4) of 10280

Other companies are beginning to patent the ICE of their own compounds, going forward. They have seen SEPR's strategy and find they can adopt it themselves. Perhaps that was what the Forbes guy was talking about. I wonder-still, as a fairly ardent and pleased long, and mostly privately--about the value some of the ICEs will have when they are on the market. I think people are hoping that Prozac II will be a new drug. It won't. Neither is Allegra a superb Seldane, as far as I can tell. Useful, yes. I wonder how sales are doing, actually. I am eager to see what SEPR comes up with for NCEs. For a biotech, they have a really cool cash-flow plan to support their original research! In the meantime, what I have seen of SEPR is that it is a hugely aggressive company, with scads of aggressive scientists and lawyers. Sure, I'll invest here. ('Specially since I've seen the shares go from 25 to 120 in a year and a half.) Of course Southwell sounds good when he's interviewed! How else could he be the CEO of this particular company?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next